D
espite improvement in insulin therapy, pancreas or islet transplantation is currently the only treatment that restores normal glucose metabolism and substantially improves the quality of life in type 1 diabetes mellitus patients (1, 2) . In patients with diabetes mellitus and end-stage renal disease, simultaneous pancreas-kidney transplantation offers lower patient mortality than in patients on the waiting list or deceased-donor kidney-only transplant recipients (3Y6). However, not all patients eligible for pancreas transplantation can benefit from this therapeutic option mainly because of the well-known shortage of donor organs. Actually, the waiting time for receiving a pancreas transplant has considerably increased in several European countries over the last years (7) . Many attempts in the United States and Europe have been made to increase the number of transplanted organs, for example, mass media campaigns that promote organ donation or the use of so-called expanded-criteria donors (8Y10). Considerably less attention has been paid to assessing whether those donor pancreases that are actually offered for allocation are appropriately used.
Considering the donor organ shortage, it is surprising that indeed not all organs of deceased donors are finally transplanted. The discrepancy between offered and actually transplanted organs is especially high in pancreas transplantation. Data from Eurotransplant (ET) indicate that only 13% of all offered kidneys and 16% of livers are discarded in contrast to 71% of offered pancreases (7) . A low utilization of pancreases is also reported in the United States: in 2005, the pancreas was recovered and transplanted in only 19% of all deceased donors (11) . Andreoni et al. described this underutilization of pancreases as a major issue in pancreas transplantation. The reasons for this pancreas underutilization in Europe and the United States are not yet well understood partly because the refusal reasons are only insufficiently recorded in the respective databases and partly because they have not yet been systematically analyzed.
The objectives of this study were (a) to describe the time points at which offered pancreases are lost in the allocation to analyze the donor characteristics that are associated with pancreas use/withdrawal, and (c) to describe the reasons that were given for refusing organ offers, also with regard to certain medical and social donor characteristics.
RESULTS

Analysis of Loss of Pancreases in the Allocation Process
Of 1758 pancreases offered for allocation, 656 (37%) were finally transplanted (pancreas transplantation alone [64] , simultaneous pancreas-kidney transplantation [579] , and pancreas transplantation combined with transplantation of other visceral organs [13] ). Eleven percent of all offered pancreases (and 29% of all transplanted) were accepted at first offer. The median number of offers required to place a pancreas was 4 (range, 1Y24). The unused pancreases were withdrawn after a median of 8 (range, 1Y33) offers to 5 centers (range, 1Y14); that is, some pancreases were offered more than once to a center for different patients. There was a tendency for the cold ischemia time (CIT) to be longer the more often a pancreas was offered before acceptance, although the differences were statistically not significant: for those organs that were offered once, the median CIT was 9.5 hr, for those offered two to four times was 9.9 hr, for those offered five to seven times was 10.4 hr, and for those offered time times and more was 12.3 hr (P=0.1).
As illustrated in Figure 1 , 748 (43%) pancreases were withdrawn from the allocation process after they had been declined by all contacted transplant centers due to the medical conditions of the donor. Two hundred fifty-four (14%) organs were discarded because they were found to be of poor quality after surgical inspection at the time of intended recovery. In six cases, the accepting center did not withdraw its acceptance, although the recovery team considered the organ to be unusable; all of these six pancreases were recovered and transplanted.
One hundred of the shipped pancreases were not used by the surgeons in the respective transplant centers: in 60 cases, the organ quality was considered to be poor or the organ was reported to have been damaged during donor surgery; these organs could not be placed elsewhere and were withdrawn from the allocation process. Forty recovered pancreases were refused because of recipient-related difficulties or an expected critically long CIT. They could not be placed elsewhere.
Analysis of Donor Characteristics
Baseline characteristics of donors whose pancreases were used and those whose pancreases were discarded are shown in Table 1 . Disparities between donors of transplanted and discarded pancreases were present but, with the exception of age and cause of death, the disparities were only small and of questionable clinical significance.
Analysis of Refusal Reasons
The mean number of different refusal reasons documented per organ was 1.6T1.0 (median, 1; range, 0Y7) and differed between transplanted (1.4T1.2; median, 1) and discarded pancreases (1.8T0.9; median, 2). Of the two organs for which six or more different reasons were given, both were transplanted.
For the identified refusal reasons, the followed categorization was developed.
1. Donor-related criteria: (a) medical and social history, as conveyed via fax or phone to the deciding transplant physicians/surgeons and (b) criteria related to the macroscopic organ quality based on (i) surgical inspection at the time of donor surgery or (ii) surgical inspection in the transplantation center (except recovery-related trauma or damage). 2. Recipient-related criteria (e.g., positive crossmatch and recipient not transplantable). 3. Logistical criteria (e.g., transport difficulties, long CIT, or lack of local capacity). 4. Technical criteria, that is, surgical aspects related to recovery (e.g., organ damage linked with recovery procedure). Because more than one reason was named for most organs, we identified a total of 2873 refusal reasons for the 1758 pancreases, the majority of which were relating to the medical history of the donor. For details, see Table 2 .
Some donor characteristics were quite unambiguous reasons for discarding a pancreas. For example, among pancreases for which ''diabetes mellitus in the donor'', ''malignancy in the donor'', or ''CIT'' were named at least once, the proportion of finally transplanted organs was less than 10% (4%, 7%, and 8%, respectively). Other mentioned criteria were obviously less distinct; for example, organs refused at least once for ''trauma in donor'', ''donor age'', or ''resuscitation'' were later transplanted in 48%, 32%, and 28% of cases, respectively. 55 (1.9) Organ damage due to recovery or packing failure 31 Decision for islet only allocation (but no procurement in the end) 10 Conflict due to procurement of other organs (vessels needed for liver or intestine) 4 Second organ for approved combined organ transplant not available (i.e., kidney, intestine, or liver) 10 Unknown/illegible, n (%) 6 (0.2) Total, n (%)
2873 (100) a This category encompasses all single medical reasons given less than 10 times (e.g., history of smoking, catecholamine or insulin administration, hypertension, hypoxia, Meckel diverticulitis, P-PASS, or cardiovascular instability of donor).
b This category encompasses all single logistical reasons given less than five times (e.g., no answer of the contacted transplant center, no amylase/lipase available, or forgotten crossmatch).
The listed criteria represent the reasons given by the transplant centers and are not necessarily identical with reasons for the final withdrawal of an organ, because an organ could be refused due to multiple reasons by different centers.
BMI, body mass index; CIT, cold ischemia time; HLA, human leukocyte antigen; ICU, intensive care unit; P-PASS, pre-procurement pancreas allocation suitability score.
Subset of Organs of Potentially High Quality
We identified 290 pancreases of supposedly high organ quality, 180 (62%) of which were transplanted. The 110 organs that were not used were discarded for the following reasons: 58 (53%) were not allocated because too many centers refused the organ offer due to donor-related medical reasons, for example, unfavorable lab results (n=34), resuscitation (n=11), trauma as cause of death (n=6), age (n=6), virology/microbiology findings (n=4), length of intensive care unit (ICU) stay (n=5), blood transfusion (n=1), or body mass index (BMI; n=1); more than one reason per organ could apply.
Subgroup Analysis: Length of ICU Stay and Age
Donors turned down due to long ICU stay (n=226) had stayed indeed longer in ICU than those donors whose organ was never refused due to ICU stay (n=1526; median, 10 vs. 3 days). The subgroup analysis, however, showed inconsistencies. Among donors who stayed in ICU for 4 to 7 days, 11% were refused at least once with explicit reference to ''ICU stay'', 32% of which were finally transplanted (Table 3) . In this subgroup, 31% had never been declined due to ICU stay and were transplanted. Among donors who stayed in ICU for 8 to 11 days (n=236), 39% were refused at least once due to ''ICU stay'' (26% transplanted in the end), whereas 14% in this group were never refused due to ''ICU stay'' and transplanted. Even in donors with an ICU stay of no longer than 0 to 3 days, ''length of ICU stay'' was named as a refusal reason (n=14), whereas 15 pancreases were transplanted, whose donors stayed in ICU for longer than 12 days. Similar findings were obtained for age (Table 4) .
DISCUSSION
The results show a profound underutilization of offered pancreases from deceased organ donors in Germany that were offered for allocation, with only 37% of all offered pancreases transplanted. This underutilization is also true for pancreases of potentially high quality, 38% of which were discarded. A small part of pancreas discards was due to technical and logistical aspects (e.g., organ damage or lack of capacity). Most organs were withdrawn after repeated refusals due to donor characteristics. The results clearly indicate that a significant element of subjective assessment of donor characteristics is involved in the refusal of pancreases. Eighty-nine percent of all offered pancreases were turned down at least once; organs that were finally transplanted were refused a median of four times before being accepted. Many donor-related characteristics that were frequently named as refusal reasons (e.g., ''trauma in donor'', ''resuscitation'', or ''donor age'') appeared to be ambiguous in the determination of pancreas quality, because 48%, 28%, and 32%, respectively, of organs refused at least once for one of these reasons were accepted and transplanted later. In addition, this is to our knowledge the first study to show that there is no consistency in assessing single donor characteristics such as ICU stay and age for determining pancreas quality. This may explain why there were no clinically significant disparities between donors whose pancreases were used and donors whose pancreases were discarded, with the exception of age (actual donors were younger).
Although the well-known phenomenon of pancreas underutilization has been described as a ''major issue in pancreas transplantation'' (11), the analysis of the underlying reasons has been only superficial so far. The strength of this study lies in the meticulous and detailed analysis of the recorded refusal reasons that were named by transplant surgeons/physicians when turning down an organ offer. Reasons for offered pancreases not resulting in a transplant have been evaluated before, but these evaluations are based on rough categories or refusal codes, such as ''donor unsuitable The refusal reasons gathered in the protocols may not, however, entirely reflect the true reason for or the complexity of the respective decisions. It is possible that a combination of unfavorable donor characteristics led to the refusal of the offer, but only one reason was communicated to ET. Although the ET personnel are trained to precisely document the given reasons and decisions, we cannot fully ensure the accuracy of the obtained information on refusal reasons, because the documentation was performed by various employees who were in charge over the years.
The main limitation of our study is that we did not link data of refusal reasons to long-term recipient and organ outcome. Therefore, it is impossible to assess whether the refusals of pancreases for certain reasons were, in retrospect, medically justified or not. Graft and recipient survival, however, are not routinely reported to the ET database.
The study of Wiseman et al. (13) was similar to our study in that it analyzed multiple characteristics of donors whose pancreas was used and compared them with donors whose pancreas was not used. In this U.S. sample, Wiseman et al. described differences in medical and social characteristics and risk factors but found that the presence of these characteristics and risk factors was also common in donors whose pancreas was transplanted. This study also quantified refusal reasons but used the rough refusal codes recorded in the Organ Procurement and Transplantation Network forms and did not link the refusal reasons to the actual donor characteristics.
Overall, a number of organ discards seem to be avoidable. This refers especially to the sample of pancreases lost due to technical and logistic reasons. For example, 31 of the 756 (4%) recovered pancreases were not used because the transplant surgeons found them to be damaged during the recovery procedure. An adequate training of recovery surgeons for pancreas recovery, or a strict selection process for recovery team candidates, seems crucial to achieve a high standard of surgical quality for pancreas procurement. One option may be to leave pancreas recovery to those centers that are actually performing pancreas transplantation (14) . The refusal of a center due to its lack of capacity is, in principle, avoidable, too. It does not necessarily lead to the loss of an organ (because another center may accept), but many unnecessary refusals prolong the allocation time and thus threaten the organ quality.
A closer look into the data reveals that by far not all donor-related reasons that were given when refusing an organ are convincing. Three groups of disputable reasons could be identified.
First, transplant surgeons named medical aspects whose relation to the pancreas quality or the potential graft and recipient survival is highly questionable (e.g., the administration of blood transfusion or a history of smoking).
Second, there are donor-related aspects that may, but do not have to, affect the quality of the pancreas (e.g., resuscitation, alcohol abuse, BMI, or trauma as cause of death) (15) . In these cases, the history alone does not automatically justify refusal; the macroscopic quality of the organ would have been crucial for an adequate decision-making. This is also shown by the finding that 48% or 28%, respectively, of pancreases that were refused by at least one center for ''trauma in donor'' or ''resuscitation'' were finally accepted and transplanted by another center.
Third, transplant surgeons turned down organs for reasons that are indeed relevant aspects for pancreas quality and prospected outcome (e.g., long ICU stay or donor age), but the cutoffs that were obviously used were not comprehensible. For example, ''length of ICU'' was used as a refusal reason for organs with any given length of ICU stay (G1 to 914 days), many of which were transplanted later by other centers.
One can only speculate on reasons that explain this finding. Lack of experience and training of the surgeons who are on call to accept or refuse organ offers can account for refusals that are medically not comprehensible. The allocation process might benefit from a more standardized approach to donor criteria and cutoffs.
Furthermore, one needs to consider that the relatively benign prognosis of the patients on the pancreas waiting list may lead surgeons to select pancreases in a more restrictive way, because the willingness to compromise is smaller than in cases of life-threatening conditions, as has been hypothesized by Wiseman et al. (13) .
It seems important to look closely at the individual refusals. If organs are refused repeatedly, much time is wasted on unproductive offers, and a ''cascade effect'' (16) can ensue. This inefficiency in the allocation system may cause longer ischemia time, as is implied by our finding of CIT tending to increase with the number of offers needed to place a pancreas, and may thus increase the rate of discarded organs; it can also lead to unequal access to donated pancreases (17) .
Additional studies of outcomes among pancreases that have been previously turned down, for example, like the one performed by Farid et al. (16) for kidney grafts (in one center), may help to distinguish among turndown causes that led to good and bad outcomes (18) . Furthermore, indepth research involving transplant surgeons may aid to better understand the decision-making process. This study highlights the need to initiate a process of establishing standardized procedures based on current best evidence, with the ultimate aim of improving pancreas utilization for the good of those in need.
MATERIALS AND METHODS
Study Design
The study is a descriptive analysis of routine data collected by ET.
ET Allocation System
In the ET pancreas allocation algorithm, the recipient candidates for a donated organ are ranked on a match list. ET offers the organ to the first recipient candidate on the match list by contacting the respective transplantation center. The reasons given by transplant centers for turning down an organ offer are recorded in detail in handwritten protocols. If a pancreas is refused by three different centers for medical reasons, or when it is not possible to reach the donor center in time, for example, due to bad weather conditions, ET is allowed to switch from a patient-oriented to a center-oriented allocation of the donor organ (''rescue allocation''). Offering starts to the centers in the donor region and consecutively to centers in adjacent regions. If no suitable recipient can be found within the ET area, the organ can be offered to countries outside ET, or the medical doctor on duty at ET will decide together with the donor coordinator to withdraw the organ. ET usually only offers pancreases from deceased donors Q5 and e50 years of age, BMI less than 30, and with no obvious contraindications (e.g., well-known cancer). In the ET region, there are currently 38 pancreas transplantation programs that have in total performed about 220 to 300 pancreas transplants per year within the study period. Compared with the United States, the pancreas transplantation activity rate (incidence per million population) in Germany is lower (4.6 vs. 1.7 in 2006) (19) .
Data Source and Management
The analysis is based on two data sources: (a) the database in which ET routinely registers medical information on deceased organ donors and (b) the handwritten ET allocation protocols that contain details about the allocation process, that is, the time at which a transplant center was contacted, whether the organ was accepted, and, if not, why it was refused. Among all deceased German organ donors from January 1, 2005 to December 31, 2009 (n=6368), those who had no contraindication for pancreas recovery and whose whole pancreas was offered to at least one transplant center were included in our analysis (n=1758). All pancreases were donated from beating heart donors.
Analysis of Loss of Pancreases in the Allocation Process
After a donation process sequence proposed by the U.S. Organ Procurement and Transplantation Network as presented by Delmonico et al. (20) , it was identified from the allocation protocols at which points of the chronological allocation and transplantation process the unused organs were finally withdrawn: (a) during the allocation process, (b) at the time of intended recovery, or (c) at the time of intended transplantation. In addition, the median number of offers that were made before an organ could be placed or was finally withdrawn was calculated as well as the median CIT for transplanted organs.
Analysis of Donor Characteristics
Using Microsoft Excel, a database was compiled, which contained the following organ donor variables: age (years), sex (male/female), BMI (kg/m 2 ), cause of death (traumatic/nontraumatic), serum levels of lipase and amylase (U/L), and length of ICU stay (days). We also included the pre-procurement pancreas allocation suitability score (P-PASS), which was created by the ET Pancreas Advisory Committee, using the nine donor parameters: age, body mass index, ICU stay, cardiac arrest, serum sodium, serum amylase and lipase, and (nor)adrenaline and dobutamine dopamine use. An organ donor with a P-PASS of less than 17 is suggested to represent an ''ideal'' donor (21) . These characteristics were compared between donors whose pancreas was discarded and donors whose pancreas was transplanted.
